(Q56418420)

English

Development and Significance of the HIV-1 Reverse Transcriptase M184V Mutation During Combination Therapy With Lamivudine, Zidovudine, and Protease Inhibitors

article

  • Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine, and protease inhibitors

Statements

Development and Significance of the HIV-1 Reverse Transcriptase M184V Mutation During Combination Therapy With Lamivudine, Zidovudine, and Protease Inhibitors (English)
0 references
Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine, and protease inhibitors (English)
0 references
Giulietta Venturi
G Venturi
0 references
Maurizio Zazzi
M Zazzi
0 references
Marinunzia Catucci
0 references
Laura Romano
0 references
Maria Letizia Riccio
0 references
Angelo De Milito
0 references
Pier E. Valensin
0 references
July 1999
0 references
1 July 1999
0 references
21
0 references
3
0 references
203
0 references
203-8
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit